Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

ACR Appropriateness Criteria® suspected osteomyelitis in patients with diabetes mellitus.

BIBLIOGRAPHIC SOURCE(S)

  • Schweitzer ME, Daffner RH, Weissman BN, Bennett DL, Blebea JS, Jacobson JA, Morrison WB, Resnik CS, Roberts CC, Rubin DA, Seeger LL, Taljanovic M, Wise JN, Payne WK, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® suspected osteomyelitis in patients with diabetes mellitus. [online publication]. Reston (VA): American College of Radiology (ACR); 2008. 7 p. [22 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Alazraki N, Dalinka MK, Berquist TH, Daffner RJ, De Smet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Imaging diagnosis of osteomyelitis in patients with diabetes mellitus. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):303-10. [20 references]

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

ACR Appropriateness Criteria®

Clinical Condition: Suspected Osteomyelitis in Patients with Diabetes Mellitus

Variant 1: Soft tissue edema without ulcer or neuroarthropathy.

Radiologic Procedure Rating Comments RRL*
X-ray foot 9 Initial study. Radiographs and MRI are complementary. Both are indicated. Min
MRI foot with contrast 9 Radiographs and MRI are complementary. Both are indicated. Useful for mapping devitalized areas preoperatively. See comments regarding contrast in the text below under "Anticipated Exceptions." None
MRI foot without contrast 9 Radiographs and MRI are complementary. Both are indicated. None
NUC Tc-99m 3-phase bone scan and In-111 WBC scan foot 4 If MRI contraindicated High
NUC Tc-99m 3-phase bone scan foot 1   Med
NUC In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
NUC Tc-99m 3-phase bone scan and In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
US foot 1   None
CT foot without contrast 1   Min
FDG-PET foot 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 2: Ulcer with no exposed bone without neuroarthropathy.

Radiologic Procedure Rating Comments RRL*
X-ray foot 9 Initial study. Radiographs and MRI are complementary. Both are indicated. Min
MRI foot with contrast 9 Radiographs and MRI are complementary. Both are indicated. Useful for mapping devitalized areas preoperatively. See comments regarding contrast in the text below under "Anticipated Exceptions." None
MRI foot without contrast 9 Radiographs and MRI are complementary. Both are indicated. None
NUC Tc-99m 3-phase bone scan and In-111 WBC scan foot 4 If MRI contraindicated High
NUC Tc-99m 3-phase bone scan foot 1   Med
NUC In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
NUC Tc-99m 3-phase bone scan and In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
US foot 1   None
CT foot without contrast 1   Min
FDG-PET foot 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 3: Ulcer with exposed bone without neuroarthropathy.

Radiologic Procedure Rating Comments RRL*
X-ray foot 9 Initial study. Radiographs and MRI are complementary. Both are indicated. Min
MRI foot with contrast 9 Radiographs and MRI are complementary. Both are indicated. Useful for mapping devitalized areas preoperatively. See comments regarding contrast in the text below under "Anticipated Exceptions." None
MRI foot without contrast 9 Radiographs and MRI are complementary. Both are indicated. None
NUC Tc-99m 3-phase bone scan and In-111 WBC scan foot 4 If MRI contraindicated High
NUC Tc-99m 3-phase bone scan foot 1   Med
NUC In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
NUC Tc-99m 3-phase bone scan and In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
US foot 1   None
CT foot without contrast 1   Min
FDG-PET foot 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 4: Neuropathy without ulcer

Radiologic Procedure Rating Comments RRL*
X-ray foot 9 Initial study. Radiographs and MRI are complementary. Both are indicated. Min
MRI foot with contrast 9 Radiographs and MRI are complementary. Both are indicated. See comments regarding contrast in text under "Anticipated Exceptions." None
MRI foot without contrast 9 Radiographs and MRI are complementary. Both are indicated. None
CT foot without contrast 5 For neuropathy or if MRI contraindicated. Min
NUC Tc-99m 3-phase bone scan foot 5 Useful for pre-radiographic findings of neuropathy. Also if MRI contraindicated. Med
NUC Tc-99m 3-phase bone scan and In-111 WBC scan foot 2   High
NUC In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
NUC Tc-99m 3-phase bone scan and In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
US foot 1   None
FDG-PET foot 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 5: Neuroarthropathy with ulcer without exposed bone.

Radiologic Procedure Rating Comments RRL*
X-ray foot 9 Initial study. Radiographs and MRI are complementary. Both are indicated. Min
MRI foot with contrast 9 Radiographs and MRI are complementary. Both are indicated. See comments regarding contrast in the text below under "Anticipated Exceptions." None
MRI foot without contrast 9 Radiographs and MRI are complementary. Both are indicated. None
NUC Tc-99m 3-phase bone scan and In-111 WBC scan foot 4 If MRI contraindicated High
NUC Tc-99m 3-phase bone scan foot 1   Med
NUC In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
NUC Tc-99m 3-phase bone scan and In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
CT foot without contrast 1   Min
US foot 1   None
FDG-PET foot 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 6: Neuroarthropathy with ulcer with exposed bone.

Radiologic Procedure Rating Comments RRL*
X-ray foot 9 Initial study. Radiographs and MRI are complementary. Both are indicated. Min
MRI foot with contrast 9 Radiographs and MRI are complementary. Both are indicated. See comments regarding contrast in the text below under "Anticipated Exceptions." None
MRI foot without contrast 9 Radiographs and MRI are complementary. Both are indicated. None
NUC Tc-99m 3-phase bone scan and In-111 WBC scan foot 4 If MRI contraindicated High
NUC Tc-99m 3-phase bone scan foot 1   Med
NUC In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
NUC Tc-99m 3-phase bone scan and In-111 WBC scan and Tc-99m sulfur colloid marrow scan foot 1   High
CT foot without contrast 1   Min
US foot 1   None
FDG-PET 1   High
Rating Scale: 1=Least appropriate, 9=Most appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Summary of Literature Review

Through the last 50 years there has been much written about the diabetic foot, with little consensus as to whether, when, and what imaging is appropriate. This overview will summarize some of the work and draw conclusions based on the available data. Several clinical situations will be discussed in which osteomyelitis or diabetic pedal disease is suspected, but clinical findings differ because of the presence or absence of edema ulceration and neuropathy.

Please note that although several of the variants have similar recommendations, they do present as unique clinical scenarios.

Soft-Tissue Edema without Ulceration

First, the probability of having osteomyelitis in a diabetic foot without evidence of ulceration is extremely low. Whether there is or is not soft-tissue swelling, these patients have almost no incidence of osteomyelitis and a low incidence of septic arthritis, but some frequency of soft-tissue infections. The only situation in which such a patient can have osteomyelitis is the presence of a "hidden" ulcer that has granulated over and may appear healed. In that situation the risk of osteomyelitis is still extremely low, since the ulcer would not have granulated over if osteomyelitis were present. Therefore, without a clinically apparent ulcer, the role of imaging might be to diagnose neuropathic disease or to see if there is soft-tissue infection only.

Neuropathy without Ulcer

A more difficult question is whether it is the neuroarthropathy or the soft-tissue infection that is causing the soft-tissue swelling. In a patient who has neuroarthropathy, the risk of infection is usually low without ulceration. Radiography can be used as a screening examination. Computed tomography (CT) may pick up neuroarthropathy, which may not be apparent radiographically and may be the cause of the swelling and pain (mimicking infection). CT can rarely exclude the diagnosis of osteomyelitis definitively if there is no edema in the marrow (fat is visible).

Scintigraphy is of indeterminate insensitivity and specificity, whether it is bone scan, indium or indium with sulfur colloid, or even positron emission tomography (PET). Flow images are the best discriminators of infection, but remain imperfect. Magnetic resonance imaging (MRI) likely has the best clinical results in this scenario with or without contrast, but the yield is going to be low in this clinical group of patients, and it is costly.

There is some importance in diagnosing neuropathic disease prior to radiographic changes, as these patients will be treated with altered footwear and orthotics to prevent the progression to deformity. Scintigraphy is, however, extremely sensitive to early neuropathic disease, long before radiographic changes are present. MRI is less sensitive but is a better test if there is a possibility of soft-tissue infection.

Ulcer with Exposed Bone

If an ulcer is present, the risk of infection is quite high, and almost invariable if the ulcer reaches bone. The role of imaging would be to confirm the infection and show extent. Radiography will show the infection, however late. Bone scan is quite nonspecific. Surprisingly, indium scan, even when combined with sulfur colloid marrow imaging, has low specificity, although if the ulcer is away from the joint these techniques are better. MRI has high specificity and sensitivity both with and without contrast. Ultrasound (US) may have promise in long bones but, to date, data about its utility in diagnosing the diabetic foot are quite limited. PET results are similarly poor, as this technique shows metabolic activity primarily and therefore is not specific.

Ulcer with Neuropathy and Exposed Bone

In patients who have diabetes and secondary neuroarthropathy, the infection is usually over an osseous abnormality with an ulcer. If the ulcer tracks down to bone, the risk of osteomyelitis is extremely high, perhaps even higher than in the preceding situation where there is an ulcer without neuropathic deformity. The overall role of imaging therefore, is more to determine the extent of the disease than to definitively diagnose it. Therefore, most authors do not advocate scintigraphy in this situation because of its relative poor spatial resolution for extent of disease; similar conclusions apply to PET.

Similarly, indium-labeled WBC (white blood cell) scanning with or without bone marrow scanning has only mixed sensitivity and specificity for osteomyelitis with neuropathy and yields poor anatomic extent of infection. Radiography has a high specificity but low sensitivity. US is unproven. CT will show the neuroarthropathic disease but not much else. MRI should be performed to determine extent of disease. T1 and fat-suppressed sequences are complementary, and contrast may or may not be used. The use of contrast is more to see the extent of the disease as well as the extent of vascularity, rather than to diagnose infections. Contrast may also help identify necrotic or poorly perfused regions, and to aid in surgical planning.

Summary and Recommendations

If a patient has an ulcer that extends to bone, there is quite likely, but not invariably, osteomyelitis. The best way to confirm this diagnosis and determine the extent of disease is with MRI. If there is no ulcer and there is still a clinical suspicion of infection, MRI is the test of choice. However, conventional radiographs should be done simultaneously in both situations. In indeterminate cases, aspiration and biopsy would be the next step.

If there is soft-tissue swelling the question is, "Is there early neuropathic disease or infection present?" Radiographs should be performed first. If the radiographs are normal, another test should be performed. If the suspicion of infection is low, the next test should probably be a three-phase bone scan. If there is a modest risk of infection, MRI is probably indicated.

Anticipated Exceptions

Nephrogenic systemic fibrosis (NSF, also known as nephrogenic fibrosing dermopathy) was first identified in 1997 and has recently generated substantial concern among radiologists, referring doctors and lay people. Until the last few years, gadolinium-based MR contrast agents were widely believed to be almost universally well tolerated, extremely safe and non-nephrotoxic, even when used in patients with impaired renal function. All available experience suggests that these agents remain generally very safe, but recently some patients with renal failure who have been exposed to gadolinium contrast agents (the percentage is unclear) have developed NSF, a syndrome that can be fatal. Further studies are necessary to determine what the exact relationships are between gadolinium-containing contrast agents, their specific components and stoichiometry, patient renal function and NSF. Current theory links the development of NSF to the administration of relatively high doses (e.g., >0.2mM/kg) and to agents in which the gadolinium is least strongly chelated. The U.S. Food and Drug Administration (FDA) has recently issued a "black box" warning concerning these contrast agents (http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm142882.htm).

This warning recommends that, until further information is available, gadolinium contrast agents should not be administered to patients with either acute or significant chronic kidney disease (estimated glomerular filtration rate [GFR] <30 mL/min/1.73m2), recent liver or kidney transplant or hepatorenal syndrome, unless a risk-benefit assessment suggests that the benefit of administration in the particular patient clearly outweighs the potential risk(s).

Abbreviations

  • CT, computed tomography
  • FDG-PET, fluorodeoxyglucose-positron emission tomography
  • In, indium
  • Med, medium
  • Min, minimal
  • MRI, magnetic resonance imaging
  • NUC, nuclear medicine
  • Tc, technetium
  • US, ultrasound
  • WBC, white blood cell

Relative Radiation Level Effective Dose Estimated Range
None 0
Minimal <0.1 mSv
Low 0.1-1 mSv
Medium 1-10 mSv
High 10-100 mSv

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on analysis of the current literature and expert panel consensus.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Schweitzer ME, Daffner RH, Weissman BN, Bennett DL, Blebea JS, Jacobson JA, Morrison WB, Resnik CS, Roberts CC, Rubin DA, Seeger LL, Taljanovic M, Wise JN, Payne WK, Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® suspected osteomyelitis in patients with diabetes mellitus. [online publication]. Reston (VA): American College of Radiology (ACR); 2008. 7 p. [22 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1995 (revised 2008)

GUIDELINE DEVELOPER(S)

American College of Radiology - Medical Specialty Society

SOURCE(S) OF FUNDING

The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

GUIDELINE COMMITTEE

Committee on Appropriateness Criteria, Expert Panel on Musculoskeletal Imaging

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: Mark E. Schweitzer, MD; Richard H. Daffner, MD; Barbara N. Weissman, MD; D. Lee Bennett, MD; Judy S. Blebea, MD; Jon A. Jacobson, MD; William B. Morrison, MD; Charles S. Resnik, MD; Catherine C. Roberts, MD; David A. Rubin, MD; Leanne L. Seeger, MD; Mihra Taljanovic, MD; James N. Wise, MD; William K. Payne, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Alazraki N, Dalinka MK, Berquist TH, Daffner RJ, De Smet AA, el-Khoury GY, Goergen TG, Keats TE, Manaster BJ, Newberg A, Pavlov H, Haralson RH, McCabe JB, Sartoris D. Imaging diagnosis of osteomyelitis in patients with diabetes mellitus. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):303-10. [20 references]

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American College of Radiology (ACR) Web site.

ACR Appropriateness Criteria® Anytime, Anywhere™ (PDA application). Available from the ACR Web site.

Print copies: Available from the American College of Radiology, 1891 Preston White Drive, Reston, VA 20191. Telephone: (703) 648-8900.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on May 6, 2001. The information was verified by the guideline developer as of June 29, 2001. This summary was updated by ECRI Institute on June 15, 2009.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo